Basel Medical Group Ltd BMGL
3.70
(0.10)
(2.63%)
as of 25 Sep
- Market cap
- $6.0M
- P/E
- —
Follow BMGL
| Jun '24 | Dec '24 | Jun '25 | Dec '25 | |
|---|---|---|---|---|
ROIC |
0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% | 0.00% |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
— | — | — | 0.00 |
Free Cash Flow |
— | — | — | (5.77) |
Capital Expenditures |
— | — | — | (0.16) |
Piotroski F-Score |
0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||
Cash ROIC |
0.00% | 0.00% | 0.00% | (42.95%) |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
— | — | — | 0.00 |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 1.08 |
Capex/Depreciation |
— | — | — | (0.59) |
Operating CF per Share |
— | — | — | 0.00 |
Capex per Share |
— | — | — | 0.00 |
Capex to Sales |
— | — | — | 0.00 |
Columns are period end dates